North America Pharmaceutical Plastic Packaging Market Size & Outlook, 2026-2031
North America Pharmaceutical Plastic Packaging Market Insights
- Packaging Market Insights analysis indicates that the North America Pharmaceutical Plastic Packaging Market size, which was USD 9.07 Billion in 2025, is projected to attain USD 16.24 Billion by 2031.
- The market is expected to register a CAGR of 10.27% over the period 2026–2031.
- In 2025, Blister Packs emerged as the dominant By product type based on market size.
- Pre-fillable Inhalers is projected to register the fastest growth, positioning it as the most attractive By product type segment over the forecast horizon.
Source: PIAnalysis Company Publications, Primary Interviews.
Other Key Findings
- North America held 37.02% share of the global Pharmaceutical Plastic Packaging Market size in 2025.
- United States is expected to remain the largest contributor to the global market size by 2031.
- By 2031, Canada is anticipated to record the highest growth in North America, with the market size expected to reach USD 4.79 Billion.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2031 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2031 |
| Market Size In 2025 | USD 9.07 Billion |
| Market Size In 2031 | USD 16.24 Billion |
| Largest segment | Blister Packs |
| Units | Revenue in USD Billion |
| CAGR | 10.27% (2026-2031) |
| Segmnetation Covered | |
| North America |
|
| By product type |
|
| By Material |
|
| By Drug Delivery Mode |
|
| By End User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
North America Pharmaceutical Plastic Packaging Market Country 2026-2031 (USD Billion)
| North America | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | XX.x | XX.x | XX.x | 6.44 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Canada | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
North America Pharmaceutical Plastic Packaging Market By product type 2026-2031 (USD Billion)
| By product type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Blister Packs | XX.x | XX.x | XX.x | 2.54 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Plastic Bottle | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| By Product Type | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pre-fillable Inhalers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Syringes & Cartridges | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ampoules & Vials | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Tubes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Containers & Jars | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
North America Pharmaceutical Plastic Packaging Market By Material 2026-2031 (USD Billion)
| By Material | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Polyethylene (PE) | XX.x | XX.x | XX.x | 2.72 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polyethylene Terephthalate (PET) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polyvinyl Chloride (PVC) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polystyrene (PS) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Polycarbonate (PC) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
North America Pharmaceutical Plastic Packaging Market By Drug Delivery Mode 2026-2031 (USD Billion)
| By Drug Delivery Mode | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral Drug Packaging | XX.x | XX.x | XX.x | 2.51 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Injectable Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Topical Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Inhalation Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ophthalmic Drug Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| By Packaging Type | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Primary Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Secondary Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Tertiary Packaging | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
North America Pharmaceutical Plastic Packaging Market By End User 2026-2031 (USD Billion)
| By End User | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Manufacturing Companies | XX.x | XX.x | XX.x | 3.66 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Contract Packaging Organizations (CPOs) | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hospitals & Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Retail Pharmacies | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.